The vascular plasminogen activator as source of the fibrinolytic potential observed during cardiopulmonary bypass.
Increased fibrinolytic activity is a well recognized constant finding observed during cardiopulmonary bypass (CPB). The purpose of the present work was to study and estimate the factors involved in the plasminogen activation and prekallikrein-kallikrein systems in a population of adult patients undergoing open heart surgery with CPB. Plasminogen activator activity determinations with a fibrinolytic method as well as plasminogen activation and prekallikrein-kallikrein determinations with synthetic substrates were carried out. Our results indicate that no active fibrinolysis but a fibrinolytic potential, similar to that observed in blood obtained after venous occlusion, can be demonstrated in circulating plasma during CPB. This fibrinolytic potential is related to the presence of vascular plasminogen activator released from endothelial cells by the CPB stimulus.
Baños
G
G
Biochemistry Department, Instituto Nacional de Cardiología Ignacio Chavez, Mexico, D.F.
de la Peña
A
A
Izaguirre
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D002315:Cardiopulmonary Bypass; D002648:Child; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D005337:Fibrin; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007610:Kallikreins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011288:Prekallikrein / Q000032:analysis; D010959:Tissue Plasminogen Activator / Q000378:metabolism* / Q000494:pharmacology
D005337:Fibrin; D011288:Prekallikrein; D007610:Kallikreins; D010959:Tissue Plasminogen Activator